| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $594.8M | +10.0% |
| Cost of Revenue | $234.6M | +8.7% |
| Gross Profit | $360.2M | +10.9% |
| R&D Expense | $127.5M | -1.5% |
| SG&A Expense | $92.4M | +2.3% |
| Operating Income | $3.7M | +120.6% |
| Pre-tax Income | $6.7M | +118.9% |
| Income Tax | -$3.0M | -19.3% |
| Net Income | $5.2M | +113.7% |
| EPS (Basic) | $0.05 | +115.2% |
| EPS (Diluted) | $0.05 | +115.2% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $88.4M | -26.9% |
| Accounts Receivable | $166.5M | +13.5% |
| Current Assets | $293.5M | -2.9% |
| Total Assets | $1.65B | +2.3% |
| Current Liabilities | $294.5M | +17.1% |
| Total Liabilities | $579.5M | +13.0% |
| Stockholders' Equity | $1.06B | -3.1% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $90.1M | +63.2% |
| Capital Expenditures | $7.5M | +313.1% |
| Investing Cash Flow | -$54.1M | +75.3% |
| Financing Cash Flow | -$73.0M | -142.8% |
| Free Cash Flow | $82.6M | +54.7% |